Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

Reproductive BioMedicine Online

Volumn 11, Issue 2, 2005, Pages 194-197

  Bose, Chinmoy K ^a  

^a NONE   (India)

Author keywords

Epithelial ovarian cancer; Follicle stimulating hormone receptor; FSH; Nerve growth factor; Ovarian surface epithelium

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN;

ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CLIMACTERIUM; EPITHELIUM; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HUMAN; HYPOPHYSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; OVARY CANCER; OVARY FOLLICLE MATURATION; OVULATION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 23144467496     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)60958-3     Document Type: Article

References (28)

1. Anderson RA, Robinson LL, Brooks J, Spears N 2002 Neurotropins and their receptors are expressed in the human fetal ovary. Journal of Clinical Endocrinology and Metabolism 87, 890-897.
2. Arslan AA, Zeleniuch-Jacquotte A, Lundin E et al. 2003 Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women. Cancer Epidemiology & Biomarkers Preview 12, 1531-1535.
3. Babu PS, Krishnamurthy H, Chedrese PJ, Sairam MR 2000 Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor, role in hormone signaling and cell proliferation. Journal of Biological Chemistry 275, 27615-27626.
4. Biskind MS, Biskind GS 1944 Development of tumours in the rest ovary after transplantation into the spleen. Proceedings of the Society of Experimental Biology and Medicine 55, 176-179.
5. Blaakaer J, Djursing H, Hording U et al. 1992 The pituitary-gonadal axis in women with benign or malignant ovarian tumours. Acta Endocrinologica 127, 127-130.
6. Bose CK 2004 Nerve growth factor, follicle stimulating hormone receptor and epithelial ovarian cancer. Medical Hypotheses 63, 917-918.
7. Bose CK 2005 Does hormone replacement therapy prevent epithelial ovarian cancer? Reproductive BioMedicine Online 11, 86-92.
8. Bose CK, Menon U, Thomas J et al. 2001 Gonadotrophin levels in postmenopausal women with epithelial ovarian cancer. Journal of Obstetrics and Gynaecology of India 51, 48-54.
9. Bose CK, Sarkar B, Sarkar S, Bose B 2004 Dynamics of endocrine feedback. www.iscid.org/boards/ubb-get⊤pic-f-26-t-000004.html [accessed 15 June 2005].
10. Davidson B, Lazarovici P, Ezersky A et al. 2001 Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clinical Cancer Research 7, 3457-3464.
11. Davidson B, Reich R, Lazarovici P et al. 2003 Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. Clinical Cancer Research 9, 2248-2259.
12. Dorfman M, Arancibia, S, Fiedler JL, Lara HE 2003 Chronic intermittent cold stress activates ovarian sympathetic nerves and modifies ovarian follicular development in the rat. Biology of Reproduction 68, 2039-2043.
13. Fleming R 2005 Recruitment prior to ovarian stimulation: ways of improving follicular recruitment. Reproductive BioMedicine Online 10, 55-59.
14. Gibbs RB 2003 Effects of ageing and long-term hormone replacement on cholinergic neurones in the medial septum and nucleus basalis magnocellularis of ovariectomized rats. Journal of Neuroendocrinology 15, 477-485.
15. Helzlsoear KJ, Alberg AJ, Gordon GB et al. 1995 Serum gonadotrophins and steroid hormone and the development of ovarian cancer. Journal of the American Medical Association 274, 1926-1930.
16. Lang UE, Gallinat J, Danker-Hopfe H, Bajbouj M, Hellweg R 2003 Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neuroscience Letters 344, 13-16.
17. Levi-Montalcini R, Angeletti P 1966 Nerve growth factor. Physiological Review 48, 534-569.
18. Mayerhoffer A, Dissen GA, Parrott JA et al. 1996 Involvement of nerve growth factor in the ovulatory cascade: Trk A receptor activation inhibits gap junctional communication between thecal cells. Endocrinology 137, 5662-5670.
19. Menon U, Riley SC, Thomas J, et al. 1999 Serum inhibin, activin, follistatin in postmenopausal women with epithelial ovarian cancer. British Journal of Obstetrics and Gynaecology 107, 1069-1074.
20. Missale C, Fiorentini C, Finardi A, Spano P 1999 Growth factors in pituitary tumors. Pituitary 3-4, 153-158.
21. Palmer SS, McKenna S, Arkinstall S 2005 Discovery of new molecules for future treatment of infertility. Reproductive BioMedicine Online 10, 45-54.
22. Parrott JA, Doraiswamy V, Kim G et al. 2001 Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Molecular and Cellular Endocrinology 172, 213-222.
23. Paskeviciute L, Roed H, Engelholm A 2002 No rules without exception: a long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer. European Journal of Cancer 38, S73.
24. Petit F, Huicq S, Gardette R et al. 2002 The neurotrophins NT3 and BDNF induce selective specification of neuropeptide coexpression and neuronal connectivity in arcuate and periventricular hypothalamic neurons in vitro. Neuroendocrinology 75, 55-69.
25. Romero C, Paredes A, Dissen GA, Ojeda SR 2002 Nerve growth factor induces the expression of functional FSH receptors in newly formed follicles of the rat ovary. Endocrinology 143, 1485-1494.
26. Tessarollo L 1998 Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Review 9, 125-137.
27. Wang J, Lin L, Parkash V et al. 2003 Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary Mullerian systems. International Journal of Cancer 103, 328-334.
28. Zheng W, Magid MS, Kramer EE, Chen YT 1996 Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. American Journal of Pathology 148, 47-53.